Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tnf Pharmaceuticals Inc (TNFA)

Tnf Pharmaceuticals Inc (TNFA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,604
  • Shares Outstanding, K 1,847
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,360 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 2.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.30
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -231.00
  • Most Recent Earnings $-18.00 on 08/19/25
  • Next Earnings Date 11/13/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.24 +60.49%
on 09/05/25
9.31 -44.15%
on 08/27/25
-1.05 (-16.80%)
since 08/22/25
3-Month
3.24 +60.49%
on 09/05/25
17.39 -70.10%
on 07/29/25
-8.78 (-62.80%)
since 06/24/25
52-Week
3.24 +60.49%
on 09/05/25
195.00 -97.33%
on 10/15/24
-128.80 (-96.12%)
since 09/24/24

Most Recent Stories

More News
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Licensed technology positions Company at forefront of new quantum-class computing paradigm

TNFA : 5.20 (+48.15%)
QCLS : 5.35 (-3.95%)
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (Nasdaq: TNFA), (“TNF” or the “Company”) today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company...

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Financing priced at a 44% premium to market Led by a top strategic investor with significant participation from existing...

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

First light- and laser-based computing system designed to outperform quantum and supercomputing and solve complex problems unfeasible for GPUs ...

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions,...

TNFA : 5.20 (+48.15%)
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Transforms present balance sheet with significant reduction in liabilities Largest shareholder is long-term strategic...

TNFA : 5.20 (+48.15%)

Business Summary

TNF Pharmaceuticals Inc. is a clinical stage pharmaceutical company committed to extending healthy lifespan. It focused on developing novel therapeutic platforms which treat the causes of disease rather than only addressing the symptoms. TNF Pharmaceuticals Inc., formerly known as MyMD Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 12.77
2nd Resistance Point 10.85
1st Resistance Point 8.03
Last Price 5.20
1st Support Level 3.29
2nd Support Level 1.37
3rd Support Level N/A

See More

52-Week High 195.00
Fibonacci 61.8% 121.75
Fibonacci 50% 99.12
Fibonacci 38.2% 76.49
Last Price 5.20
52-Week Low 3.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar